Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

RAYVOW 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/RAYVOW 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Approved

STANDARD

RAYVOW 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Eli Lilly Nederland B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Sep 16, 2022
Approval ID: 37b3e3162948e99e
Company: Eli Lilly Nederland B.V.
Type: Standard

Approval Details

Approval Id: 37b3e3162948e99e
Drug Cima Aemps Name: RAYVOW 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number: 1211587016
Holder Company Name: Eli Lilly Nederland B.V.
Marketing Company Name: Organon Salud S.L.
Holder Company Detail Path: /organization/eli-lilly-nederland-bv
Authorization Date: 2022-09-16
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 100 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Eli Lilly Nederland B.V.
Company Detail Path: /organization/eli-lilly-nederland-bv

Company Information

Pharmaceutical Company Name: Eli Lilly Nederland BV
Country Name: Netherlands
Website: http://www.lilly.com/nl

Active Ingredients

LASMIDITAN SUCCINATO

115,65 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 16, 2022

Approval ID

37b3e3162948e99e

Type

Standard

Back to CIMA-AEMPS Approvals